nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—SLC6A4—epilepsy syndrome	0.107	0.317	CbGaD
Levomilnacipran—CYP2C19—epilepsy syndrome	0.102	0.301	CbGaD
Levomilnacipran—CYP2D6—epilepsy syndrome	0.0754	0.223	CbGaD
Levomilnacipran—ABCB1—epilepsy syndrome	0.0538	0.159	CbGaD
Levomilnacipran—CYP2C8—Trimethadione—epilepsy syndrome	0.0185	0.0433	CbGbCtD
Levomilnacipran—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0174	0.0407	CbGbCtD
Levomilnacipran—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0167	0.0391	CbGbCtD
Levomilnacipran—CYP2C19—Felbamate—epilepsy syndrome	0.0155	0.0363	CbGbCtD
Levomilnacipran—CYP2C19—Trimethadione—epilepsy syndrome	0.0155	0.0363	CbGbCtD
Levomilnacipran—ABCB1—Levetiracetam—epilepsy syndrome	0.0147	0.0345	CbGbCtD
Levomilnacipran—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0146	0.0341	CbGbCtD
Levomilnacipran—CYP2C19—Clobazam—epilepsy syndrome	0.0126	0.0296	CbGbCtD
Levomilnacipran—CYP2C8—Carbamazepine—epilepsy syndrome	0.0125	0.0292	CbGbCtD
Levomilnacipran—CYP2C8—Primidone—epilepsy syndrome	0.0117	0.0273	CbGbCtD
Levomilnacipran—CYP2C8—Phenytoin—epilepsy syndrome	0.0112	0.0262	CbGbCtD
Levomilnacipran—CYP2C19—Carbamazepine—epilepsy syndrome	0.0105	0.0245	CbGbCtD
Levomilnacipran—CYP2C8—Propofol—epilepsy syndrome	0.0104	0.0245	CbGbCtD
Levomilnacipran—ABCB1—Clobazam—epilepsy syndrome	0.0102	0.0239	CbGbCtD
Levomilnacipran—CYP2C8—Phenobarbital—epilepsy syndrome	0.00998	0.0234	CbGbCtD
Levomilnacipran—ABCB1—Lamotrigine—epilepsy syndrome	0.00982	0.023	CbGbCtD
Levomilnacipran—CYP2C19—Primidone—epilepsy syndrome	0.00978	0.0229	CbGbCtD
Levomilnacipran—CYP2C8—Diazepam—epilepsy syndrome	0.00947	0.0222	CbGbCtD
Levomilnacipran—CYP2C19—Phenytoin—epilepsy syndrome	0.0094	0.022	CbGbCtD
Levomilnacipran—CYP2C19—Propofol—epilepsy syndrome	0.00876	0.0205	CbGbCtD
Levomilnacipran—ABCB1—Carbamazepine—epilepsy syndrome	0.00845	0.0198	CbGbCtD
Levomilnacipran—CYP2C19—Phenobarbital—epilepsy syndrome	0.00838	0.0196	CbGbCtD
Levomilnacipran—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00807	0.0189	CbGbCtD
Levomilnacipran—CYP2C19—Diazepam—epilepsy syndrome	0.00794	0.0186	CbGbCtD
Levomilnacipran—CYP2C19—Zonisamide—epilepsy syndrome	0.00775	0.0181	CbGbCtD
Levomilnacipran—ABCB1—Phenytoin—epilepsy syndrome	0.00758	0.0178	CbGbCtD
Levomilnacipran—CYP3A4—Trimethadione—epilepsy syndrome	0.0075	0.0176	CbGbCtD
Levomilnacipran—CYP3A4—Felbamate—epilepsy syndrome	0.0075	0.0176	CbGbCtD
Levomilnacipran—CYP2C8—Valproic Acid—epilepsy syndrome	0.00746	0.0175	CbGbCtD
Levomilnacipran—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00705	0.0165	CbGbCtD
Levomilnacipran—ABCB1—Phenobarbital—epilepsy syndrome	0.00676	0.0158	CbGbCtD
Levomilnacipran—ABCB1—Midazolam—epilepsy syndrome	0.00666	0.0156	CbGbCtD
Levomilnacipran—CYP2D6—Propofol—epilepsy syndrome	0.00666	0.0156	CbGbCtD
Levomilnacipran—ABCB1—Diazepam—epilepsy syndrome	0.00641	0.015	CbGbCtD
Levomilnacipran—CYP3A4—Clonazepam—epilepsy syndrome	0.00638	0.0149	CbGbCtD
Levomilnacipran—CYP2C19—Valproic Acid—epilepsy syndrome	0.00626	0.0147	CbGbCtD
Levomilnacipran—CYP3A4—Clobazam—epilepsy syndrome	0.00611	0.0143	CbGbCtD
Levomilnacipran—CYP2C19—Topiramate—epilepsy syndrome	0.00565	0.0132	CbGbCtD
Levomilnacipran—CYP3A4—Rufinamide—epilepsy syndrome	0.0052	0.0122	CbGbCtD
Levomilnacipran—CYP3A4—Carbamazepine—epilepsy syndrome	0.00507	0.0119	CbGbCtD
Levomilnacipran—CYP3A4—Primidone—epilepsy syndrome	0.00473	0.0111	CbGbCtD
Levomilnacipran—CYP3A4—Phenytoin—epilepsy syndrome	0.00454	0.0106	CbGbCtD
Levomilnacipran—CYP3A4—Propofol—epilepsy syndrome	0.00424	0.00992	CbGbCtD
Levomilnacipran—CYP3A4—Acetazolamide—epilepsy syndrome	0.00405	0.00948	CbGbCtD
Levomilnacipran—CYP3A4—Phenobarbital—epilepsy syndrome	0.00405	0.00948	CbGbCtD
Levomilnacipran—CYP3A4—Midazolam—epilepsy syndrome	0.00399	0.00935	CbGbCtD
Levomilnacipran—SLC6A2—locus ceruleus—epilepsy syndrome	0.00392	0.151	CbGeAlD
Levomilnacipran—CYP3A4—Diazepam—epilepsy syndrome	0.00384	0.00899	CbGbCtD
Levomilnacipran—CYP3A4—Zonisamide—epilepsy syndrome	0.00375	0.00877	CbGbCtD
Levomilnacipran—CYP3A4—Valproic Acid—epilepsy syndrome	0.00303	0.00709	CbGbCtD
Levomilnacipran—CYP3A4—Topiramate—epilepsy syndrome	0.00273	0.00639	CbGbCtD
Levomilnacipran—SLC6A2—autonomic nervous system—epilepsy syndrome	0.00208	0.08	CbGeAlD
Levomilnacipran—SLC6A4—ganglion—epilepsy syndrome	0.00131	0.0505	CbGeAlD
Levomilnacipran—SLC6A2—ganglion—epilepsy syndrome	0.00116	0.0444	CbGeAlD
Levomilnacipran—CYP2J2—forebrain—epilepsy syndrome	0.00102	0.0393	CbGeAlD
Levomilnacipran—SLC6A4—hindbrain—epilepsy syndrome	0.000997	0.0383	CbGeAlD
Levomilnacipran—CYP2J2—telencephalon—epilepsy syndrome	0.00094	0.0361	CbGeAlD
Levomilnacipran—CYP2J2—medulla oblongata—epilepsy syndrome	0.000739	0.0284	CbGeAlD
Levomilnacipran—Milnacipran—SLC6A4—epilepsy syndrome	0.000725	0.257	CrCbGaD
Levomilnacipran—CYP2J2—midbrain—epilepsy syndrome	0.000675	0.0259	CbGeAlD
Levomilnacipran—CYP2J2—spinal cord—epilepsy syndrome	0.000659	0.0253	CbGeAlD
Levomilnacipran—Pethidine—GRIN2A—epilepsy syndrome	0.000625	0.222	CrCbGaD
Levomilnacipran—CYP2J2—head—epilepsy syndrome	0.000585	0.0225	CbGeAlD
Levomilnacipran—SLC6A4—brainstem—epilepsy syndrome	0.000571	0.0219	CbGeAlD
Levomilnacipran—CYP2J2—nervous system—epilepsy syndrome	0.000555	0.0213	CbGeAlD
Levomilnacipran—SLC6A4—forebrain—epilepsy syndrome	0.000551	0.0212	CbGeAlD
Levomilnacipran—CYP2J2—central nervous system—epilepsy syndrome	0.000534	0.0205	CbGeAlD
Levomilnacipran—Pethidine—GRIN2B—epilepsy syndrome	0.000532	0.189	CrCbGaD
Levomilnacipran—CYP2J2—cerebellum—epilepsy syndrome	0.000522	0.0201	CbGeAlD
Levomilnacipran—SLC6A4—telencephalon—epilepsy syndrome	0.000507	0.0195	CbGeAlD
Levomilnacipran—SLC6A2—brainstem—epilepsy syndrome	0.000503	0.0193	CbGeAlD
Levomilnacipran—SLC6A2—forebrain—epilepsy syndrome	0.000485	0.0186	CbGeAlD
Levomilnacipran—CYP2D6—hindbrain—epilepsy syndrome	0.00048	0.0185	CbGeAlD
Levomilnacipran—SLC6A2—telencephalon—epilepsy syndrome	0.000446	0.0171	CbGeAlD
Levomilnacipran—CYP2J2—brain—epilepsy syndrome	0.000424	0.0163	CbGeAlD
Levomilnacipran—SLC6A4—midbrain—epilepsy syndrome	0.000364	0.014	CbGeAlD
Levomilnacipran—SLC6A4—spinal cord—epilepsy syndrome	0.000355	0.0136	CbGeAlD
Levomilnacipran—SLC6A2—medulla oblongata—epilepsy syndrome	0.000351	0.0135	CbGeAlD
Levomilnacipran—Pethidine—OPRM1—epilepsy syndrome	0.000341	0.121	CrCbGaD
Levomilnacipran—SLC6A4—head—epilepsy syndrome	0.000316	0.0121	CbGeAlD
Levomilnacipran—SLC6A4—nervous system—epilepsy syndrome	0.000299	0.0115	CbGeAlD
Levomilnacipran—SLC6A4—central nervous system—epilepsy syndrome	0.000288	0.0111	CbGeAlD
Levomilnacipran—SLC6A2—head—epilepsy syndrome	0.000278	0.0107	CbGeAlD
Levomilnacipran—CYP2D6—brainstem—epilepsy syndrome	0.000275	0.0106	CbGeAlD
Levomilnacipran—CYP2D6—forebrain—epilepsy syndrome	0.000266	0.0102	CbGeAlD
Levomilnacipran—SLC6A2—nervous system—epilepsy syndrome	0.000263	0.0101	CbGeAlD
Levomilnacipran—SLC6A2—central nervous system—epilepsy syndrome	0.000254	0.00974	CbGeAlD
Levomilnacipran—CYP2D6—telencephalon—epilepsy syndrome	0.000244	0.00939	CbGeAlD
Levomilnacipran—SLC6A4—brain—epilepsy syndrome	0.000229	0.00879	CbGeAlD
Levomilnacipran—SLC6A2—brain—epilepsy syndrome	0.000201	0.00774	CbGeAlD
Levomilnacipran—ABCB1—forebrain—epilepsy syndrome	0.000191	0.00734	CbGeAlD
Levomilnacipran—Pethidine—SLC6A4—epilepsy syndrome	0.000188	0.0666	CrCbGaD
Levomilnacipran—Pethidine—CYP2C19—epilepsy syndrome	0.000178	0.0631	CrCbGaD
Levomilnacipran—ABCB1—telencephalon—epilepsy syndrome	0.000176	0.00675	CbGeAlD
Levomilnacipran—CYP2C8—brain—epilepsy syndrome	0.000165	0.00635	CbGeAlD
Levomilnacipran—CYP2D6—head—epilepsy syndrome	0.000152	0.00584	CbGeAlD
Levomilnacipran—CYP3A4—nervous system—epilepsy syndrome	0.000147	0.00563	CbGeAlD
Levomilnacipran—CYP2D6—nervous system—epilepsy syndrome	0.000144	0.00554	CbGeAlD
Levomilnacipran—CYP3A4—central nervous system—epilepsy syndrome	0.000141	0.00542	CbGeAlD
Levomilnacipran—CYP2D6—central nervous system—epilepsy syndrome	0.000139	0.00533	CbGeAlD
Levomilnacipran—ABCB1—medulla oblongata—epilepsy syndrome	0.000138	0.0053	CbGeAlD
Levomilnacipran—CYP2D6—cerebellum—epilepsy syndrome	0.000136	0.00521	CbGeAlD
Levomilnacipran—Pethidine—CYP2D6—epilepsy syndrome	0.000132	0.0468	CrCbGaD
Levomilnacipran—ABCB1—midbrain—epilepsy syndrome	0.000126	0.00485	CbGeAlD
Levomilnacipran—ABCB1—spinal cord—epilepsy syndrome	0.000123	0.00473	CbGeAlD
Levomilnacipran—CYP2D6—brain—epilepsy syndrome	0.00011	0.00424	CbGeAlD
Levomilnacipran—ABCB1—head—epilepsy syndrome	0.000109	0.0042	CbGeAlD
Levomilnacipran—ABCB1—nervous system—epilepsy syndrome	0.000104	0.00399	CbGeAlD
Levomilnacipran—ABCB1—central nervous system—epilepsy syndrome	9.99e-05	0.00384	CbGeAlD
Levomilnacipran—Pethidine—ALB—epilepsy syndrome	9.88e-05	0.035	CrCbGaD
Levomilnacipran—ABCB1—cerebellum—epilepsy syndrome	9.77e-05	0.00375	CbGeAlD
Levomilnacipran—ABCB1—brain—epilepsy syndrome	7.93e-05	0.00305	CbGeAlD
Levomilnacipran—Hepatitis—Topiramate—epilepsy syndrome	5.2e-05	0.000328	CcSEcCtD
Levomilnacipran—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.2e-05	0.000328	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Valproic Acid—epilepsy syndrome	5.19e-05	0.000328	CcSEcCtD
Levomilnacipran—Palpitations—Pregabalin—epilepsy syndrome	5.19e-05	0.000328	CcSEcCtD
Levomilnacipran—Asthenia—Phenytoin—epilepsy syndrome	5.19e-05	0.000327	CcSEcCtD
Levomilnacipran—Nausea—Midazolam—epilepsy syndrome	5.18e-05	0.000327	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Topiramate—epilepsy syndrome	5.18e-05	0.000327	CcSEcCtD
Levomilnacipran—Hallucination—Topiramate—epilepsy syndrome	5.18e-05	0.000327	CcSEcCtD
Levomilnacipran—Tachycardia—Valproic Acid—epilepsy syndrome	5.17e-05	0.000327	CcSEcCtD
Levomilnacipran—Diarrhoea—Zonisamide—epilepsy syndrome	5.17e-05	0.000326	CcSEcCtD
Levomilnacipran—Loss of consciousness—Pregabalin—epilepsy syndrome	5.16e-05	0.000326	CcSEcCtD
Levomilnacipran—Asthenia—Oxcarbazepine—epilepsy syndrome	5.16e-05	0.000326	CcSEcCtD
Levomilnacipran—Pruritus—Clonazepam—epilepsy syndrome	5.15e-05	0.000325	CcSEcCtD
Levomilnacipran—Vomiting—Vigabatrin—epilepsy syndrome	5.15e-05	0.000325	CcSEcCtD
Levomilnacipran—Skin disorder—Valproic Acid—epilepsy syndrome	5.15e-05	0.000325	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Topiramate—epilepsy syndrome	5.14e-05	0.000324	CcSEcCtD
Levomilnacipran—Oedema peripheral—Topiramate—epilepsy syndrome	5.13e-05	0.000324	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.12e-05	0.000323	CcSEcCtD
Levomilnacipran—Pruritus—Phenytoin—epilepsy syndrome	5.11e-05	0.000323	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Topiramate—epilepsy syndrome	5.11e-05	0.000323	CcSEcCtD
Levomilnacipran—Nausea—Levetiracetam—epilepsy syndrome	5.11e-05	0.000323	CcSEcCtD
Levomilnacipran—Rash—Vigabatrin—epilepsy syndrome	5.11e-05	0.000322	CcSEcCtD
Levomilnacipran—Dizziness—Felbamate—epilepsy syndrome	5.1e-05	0.000322	CcSEcCtD
Levomilnacipran—Dermatitis—Vigabatrin—epilepsy syndrome	5.1e-05	0.000322	CcSEcCtD
Levomilnacipran—Urethral disorder—Topiramate—epilepsy syndrome	5.1e-05	0.000322	CcSEcCtD
Levomilnacipran—Pruritus—Oxcarbazepine—epilepsy syndrome	5.09e-05	0.000321	CcSEcCtD
Levomilnacipran—Convulsion—Pregabalin—epilepsy syndrome	5.09e-05	0.000321	CcSEcCtD
Levomilnacipran—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.08e-05	0.000321	CcSEcCtD
Levomilnacipran—Vision blurred—Gabapentin—epilepsy syndrome	5.07e-05	0.00032	CcSEcCtD
Levomilnacipran—Headache—Vigabatrin—epilepsy syndrome	5.07e-05	0.00032	CcSEcCtD
Levomilnacipran—Hypertension—Pregabalin—epilepsy syndrome	5.07e-05	0.00032	CcSEcCtD
Levomilnacipran—Vomiting—Diazepam—epilepsy syndrome	5.07e-05	0.00032	CcSEcCtD
Levomilnacipran—Anorexia—Valproic Acid—epilepsy syndrome	5.05e-05	0.000319	CcSEcCtD
Levomilnacipran—Tremor—Gabapentin—epilepsy syndrome	5.04e-05	0.000318	CcSEcCtD
Levomilnacipran—Rash—Diazepam—epilepsy syndrome	5.03e-05	0.000317	CcSEcCtD
Levomilnacipran—Dermatitis—Diazepam—epilepsy syndrome	5.02e-05	0.000317	CcSEcCtD
Levomilnacipran—Chest pain—Pregabalin—epilepsy syndrome	5e-05	0.000316	CcSEcCtD
Levomilnacipran—Dizziness—Zonisamide—epilepsy syndrome	4.99e-05	0.000315	CcSEcCtD
Levomilnacipran—Headache—Diazepam—epilepsy syndrome	4.99e-05	0.000315	CcSEcCtD
Levomilnacipran—Anxiety—Pregabalin—epilepsy syndrome	4.98e-05	0.000314	CcSEcCtD
Levomilnacipran—Diarrhoea—Clonazepam—epilepsy syndrome	4.98e-05	0.000314	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.96e-05	0.000313	CcSEcCtD
Levomilnacipran—Hypotension—Valproic Acid—epilepsy syndrome	4.95e-05	0.000313	CcSEcCtD
Levomilnacipran—Asthenia—Carbamazepine—epilepsy syndrome	4.95e-05	0.000313	CcSEcCtD
Levomilnacipran—Agitation—Gabapentin—epilepsy syndrome	4.95e-05	0.000312	CcSEcCtD
Levomilnacipran—Diarrhoea—Phenytoin—epilepsy syndrome	4.95e-05	0.000312	CcSEcCtD
Levomilnacipran—Nausea—Fosphenytoin—epilepsy syndrome	4.93e-05	0.000312	CcSEcCtD
Levomilnacipran—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.92e-05	0.000311	CcSEcCtD
Levomilnacipran—Erythema multiforme—Topiramate—epilepsy syndrome	4.92e-05	0.000311	CcSEcCtD
Levomilnacipran—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.91e-05	0.00031	CcSEcCtD
Levomilnacipran—Vomiting—Felbamate—epilepsy syndrome	4.91e-05	0.00031	CcSEcCtD
Levomilnacipran—Dry mouth—Pregabalin—epilepsy syndrome	4.89e-05	0.000309	CcSEcCtD
Levomilnacipran—Pruritus—Carbamazepine—epilepsy syndrome	4.88e-05	0.000308	CcSEcCtD
Levomilnacipran—Rash—Felbamate—epilepsy syndrome	4.86e-05	0.000307	CcSEcCtD
Levomilnacipran—Eye disorder—Topiramate—epilepsy syndrome	4.86e-05	0.000307	CcSEcCtD
Levomilnacipran—Dermatitis—Felbamate—epilepsy syndrome	4.86e-05	0.000307	CcSEcCtD
Levomilnacipran—Headache—Felbamate—epilepsy syndrome	4.83e-05	0.000305	CcSEcCtD
Levomilnacipran—Cardiac disorder—Topiramate—epilepsy syndrome	4.83e-05	0.000305	CcSEcCtD
Levomilnacipran—Flushing—Topiramate—epilepsy syndrome	4.83e-05	0.000305	CcSEcCtD
Levomilnacipran—Syncope—Gabapentin—epilepsy syndrome	4.83e-05	0.000305	CcSEcCtD
Levomilnacipran—Leukopenia—Gabapentin—epilepsy syndrome	4.82e-05	0.000304	CcSEcCtD
Levomilnacipran—Dizziness—Clonazepam—epilepsy syndrome	4.81e-05	0.000304	CcSEcCtD
Levomilnacipran—Nausea—Vigabatrin—epilepsy syndrome	4.81e-05	0.000304	CcSEcCtD
Levomilnacipran—Vomiting—Zonisamide—epilepsy syndrome	4.8e-05	0.000303	CcSEcCtD
Levomilnacipran—Insomnia—Valproic Acid—epilepsy syndrome	4.79e-05	0.000303	CcSEcCtD
Levomilnacipran—Asthenia—Lamotrigine—epilepsy syndrome	4.79e-05	0.000302	CcSEcCtD
Levomilnacipran—Dizziness—Phenytoin—epilepsy syndrome	4.78e-05	0.000302	CcSEcCtD
Levomilnacipran—Rash—Zonisamide—epilepsy syndrome	4.76e-05	0.000301	CcSEcCtD
Levomilnacipran—Infection—Pregabalin—epilepsy syndrome	4.76e-05	0.000301	CcSEcCtD
Levomilnacipran—Paraesthesia—Valproic Acid—epilepsy syndrome	4.76e-05	0.0003	CcSEcCtD
Levomilnacipran—Palpitations—Gabapentin—epilepsy syndrome	4.76e-05	0.0003	CcSEcCtD
Levomilnacipran—Dermatitis—Zonisamide—epilepsy syndrome	4.76e-05	0.0003	CcSEcCtD
Levomilnacipran—Dizziness—Oxcarbazepine—epilepsy syndrome	4.76e-05	0.0003	CcSEcCtD
Levomilnacipran—Nausea—Diazepam—epilepsy syndrome	4.73e-05	0.000299	CcSEcCtD
Levomilnacipran—Loss of consciousness—Gabapentin—epilepsy syndrome	4.73e-05	0.000299	CcSEcCtD
Levomilnacipran—Headache—Zonisamide—epilepsy syndrome	4.73e-05	0.000299	CcSEcCtD
Levomilnacipran—Dyspnoea—Valproic Acid—epilepsy syndrome	4.72e-05	0.000298	CcSEcCtD
Levomilnacipran—Diarrhoea—Carbamazepine—epilepsy syndrome	4.72e-05	0.000298	CcSEcCtD
Levomilnacipran—Angiopathy—Topiramate—epilepsy syndrome	4.72e-05	0.000298	CcSEcCtD
Levomilnacipran—Pruritus—Lamotrigine—epilepsy syndrome	4.72e-05	0.000298	CcSEcCtD
Levomilnacipran—Shock—Pregabalin—epilepsy syndrome	4.71e-05	0.000298	CcSEcCtD
Levomilnacipran—Somnolence—Valproic Acid—epilepsy syndrome	4.71e-05	0.000297	CcSEcCtD
Levomilnacipran—Nervous system disorder—Pregabalin—epilepsy syndrome	4.7e-05	0.000297	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.69e-05	0.000296	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Topiramate—epilepsy syndrome	4.69e-05	0.000296	CcSEcCtD
Levomilnacipran—Tachycardia—Pregabalin—epilepsy syndrome	4.68e-05	0.000295	CcSEcCtD
Levomilnacipran—Chills—Topiramate—epilepsy syndrome	4.67e-05	0.000295	CcSEcCtD
Levomilnacipran—Dyspepsia—Valproic Acid—epilepsy syndrome	4.67e-05	0.000295	CcSEcCtD
Levomilnacipran—Convulsion—Gabapentin—epilepsy syndrome	4.66e-05	0.000294	CcSEcCtD
Levomilnacipran—Skin disorder—Pregabalin—epilepsy syndrome	4.65e-05	0.000294	CcSEcCtD
Levomilnacipran—Hypertension—Gabapentin—epilepsy syndrome	4.65e-05	0.000293	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.63e-05	0.000292	CcSEcCtD
Levomilnacipran—Vomiting—Clonazepam—epilepsy syndrome	4.63e-05	0.000292	CcSEcCtD
Levomilnacipran—Decreased appetite—Valproic Acid—epilepsy syndrome	4.61e-05	0.000291	CcSEcCtD
Levomilnacipran—Vomiting—Phenytoin—epilepsy syndrome	4.6e-05	0.00029	CcSEcCtD
Levomilnacipran—Rash—Clonazepam—epilepsy syndrome	4.59e-05	0.00029	CcSEcCtD
Levomilnacipran—Dermatitis—Clonazepam—epilepsy syndrome	4.58e-05	0.000289	CcSEcCtD
Levomilnacipran—Chest pain—Gabapentin—epilepsy syndrome	4.58e-05	0.000289	CcSEcCtD
Levomilnacipran—Nausea—Felbamate—epilepsy syndrome	4.58e-05	0.000289	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.58e-05	0.000289	CcSEcCtD
Levomilnacipran—Vomiting—Oxcarbazepine—epilepsy syndrome	4.57e-05	0.000289	CcSEcCtD
Levomilnacipran—Fatigue—Valproic Acid—epilepsy syndrome	4.57e-05	0.000288	CcSEcCtD
Levomilnacipran—Anxiety—Gabapentin—epilepsy syndrome	4.57e-05	0.000288	CcSEcCtD
Levomilnacipran—Anorexia—Pregabalin—epilepsy syndrome	4.57e-05	0.000288	CcSEcCtD
Levomilnacipran—Dizziness—Carbamazepine—epilepsy syndrome	4.56e-05	0.000288	CcSEcCtD
Levomilnacipran—Diarrhoea—Lamotrigine—epilepsy syndrome	4.56e-05	0.000288	CcSEcCtD
Levomilnacipran—Headache—Clonazepam—epilepsy syndrome	4.56e-05	0.000288	CcSEcCtD
Levomilnacipran—Rash—Phenytoin—epilepsy syndrome	4.56e-05	0.000288	CcSEcCtD
Levomilnacipran—Mental disorder—Topiramate—epilepsy syndrome	4.56e-05	0.000288	CcSEcCtD
Levomilnacipran—Dermatitis—Phenytoin—epilepsy syndrome	4.55e-05	0.000288	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.55e-05	0.000287	CcSEcCtD
Levomilnacipran—Rash—Oxcarbazepine—epilepsy syndrome	4.53e-05	0.000286	CcSEcCtD
Levomilnacipran—Constipation—Valproic Acid—epilepsy syndrome	4.53e-05	0.000286	CcSEcCtD
Levomilnacipran—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.53e-05	0.000286	CcSEcCtD
Levomilnacipran—Headache—Phenytoin—epilepsy syndrome	4.53e-05	0.000286	CcSEcCtD
Levomilnacipran—Malnutrition—Topiramate—epilepsy syndrome	4.53e-05	0.000286	CcSEcCtD
Levomilnacipran—Headache—Oxcarbazepine—epilepsy syndrome	4.51e-05	0.000284	CcSEcCtD
Levomilnacipran—Nausea—Zonisamide—epilepsy syndrome	4.49e-05	0.000283	CcSEcCtD
Levomilnacipran—Dry mouth—Gabapentin—epilepsy syndrome	4.48e-05	0.000283	CcSEcCtD
Levomilnacipran—Hypotension—Pregabalin—epilepsy syndrome	4.48e-05	0.000283	CcSEcCtD
Levomilnacipran—Flatulence—Topiramate—epilepsy syndrome	4.46e-05	0.000282	CcSEcCtD
Levomilnacipran—Tension—Topiramate—epilepsy syndrome	4.44e-05	0.000281	CcSEcCtD
Levomilnacipran—Dysgeusia—Topiramate—epilepsy syndrome	4.44e-05	0.00028	CcSEcCtD
Levomilnacipran—Dizziness—Lamotrigine—epilepsy syndrome	4.41e-05	0.000278	CcSEcCtD
Levomilnacipran—Vomiting—Carbamazepine—epilepsy syndrome	4.39e-05	0.000277	CcSEcCtD
Levomilnacipran—Infection—Gabapentin—epilepsy syndrome	4.36e-05	0.000276	CcSEcCtD
Levomilnacipran—Rash—Carbamazepine—epilepsy syndrome	4.35e-05	0.000275	CcSEcCtD
Levomilnacipran—Dermatitis—Carbamazepine—epilepsy syndrome	4.35e-05	0.000274	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.33e-05	0.000274	CcSEcCtD
Levomilnacipran—Insomnia—Pregabalin—epilepsy syndrome	4.33e-05	0.000274	CcSEcCtD
Levomilnacipran—Nausea—Clonazepam—epilepsy syndrome	4.32e-05	0.000273	CcSEcCtD
Levomilnacipran—Headache—Carbamazepine—epilepsy syndrome	4.32e-05	0.000273	CcSEcCtD
Levomilnacipran—Shock—Gabapentin—epilepsy syndrome	4.32e-05	0.000273	CcSEcCtD
Levomilnacipran—Nervous system disorder—Gabapentin—epilepsy syndrome	4.31e-05	0.000272	CcSEcCtD
Levomilnacipran—Paraesthesia—Pregabalin—epilepsy syndrome	4.3e-05	0.000272	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.3e-05	0.000272	CcSEcCtD
Levomilnacipran—Nausea—Phenytoin—epilepsy syndrome	4.29e-05	0.000271	CcSEcCtD
Levomilnacipran—Tachycardia—Gabapentin—epilepsy syndrome	4.29e-05	0.000271	CcSEcCtD
Levomilnacipran—Dyspnoea—Pregabalin—epilepsy syndrome	4.27e-05	0.00027	CcSEcCtD
Levomilnacipran—Nausea—Oxcarbazepine—epilepsy syndrome	4.27e-05	0.00027	CcSEcCtD
Levomilnacipran—Vision blurred—Topiramate—epilepsy syndrome	4.27e-05	0.000269	CcSEcCtD
Levomilnacipran—Skin disorder—Gabapentin—epilepsy syndrome	4.27e-05	0.000269	CcSEcCtD
Levomilnacipran—Somnolence—Pregabalin—epilepsy syndrome	4.26e-05	0.000269	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.25e-05	0.000268	CcSEcCtD
Levomilnacipran—Tremor—Topiramate—epilepsy syndrome	4.24e-05	0.000268	CcSEcCtD
Levomilnacipran—Vomiting—Lamotrigine—epilepsy syndrome	4.24e-05	0.000268	CcSEcCtD
Levomilnacipran—Urticaria—Valproic Acid—epilepsy syndrome	4.21e-05	0.000266	CcSEcCtD
Levomilnacipran—Rash—Lamotrigine—epilepsy syndrome	4.21e-05	0.000265	CcSEcCtD
Levomilnacipran—Dermatitis—Lamotrigine—epilepsy syndrome	4.2e-05	0.000265	CcSEcCtD
Levomilnacipran—Body temperature increased—Valproic Acid—epilepsy syndrome	4.19e-05	0.000265	CcSEcCtD
Levomilnacipran—Abdominal pain—Valproic Acid—epilepsy syndrome	4.19e-05	0.000265	CcSEcCtD
Levomilnacipran—Anorexia—Gabapentin—epilepsy syndrome	4.19e-05	0.000264	CcSEcCtD
Levomilnacipran—Headache—Lamotrigine—epilepsy syndrome	4.18e-05	0.000264	CcSEcCtD
Levomilnacipran—Decreased appetite—Pregabalin—epilepsy syndrome	4.17e-05	0.000263	CcSEcCtD
Levomilnacipran—Agitation—Topiramate—epilepsy syndrome	4.16e-05	0.000263	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.14e-05	0.000261	CcSEcCtD
Levomilnacipran—Fatigue—Pregabalin—epilepsy syndrome	4.13e-05	0.000261	CcSEcCtD
Levomilnacipran—Hypotension—Gabapentin—epilepsy syndrome	4.11e-05	0.000259	CcSEcCtD
Levomilnacipran—Nausea—Carbamazepine—epilepsy syndrome	4.1e-05	0.000259	CcSEcCtD
Levomilnacipran—Constipation—Pregabalin—epilepsy syndrome	4.1e-05	0.000259	CcSEcCtD
Levomilnacipran—Syncope—Topiramate—epilepsy syndrome	4.06e-05	0.000256	CcSEcCtD
Levomilnacipran—Leukopenia—Topiramate—epilepsy syndrome	4.05e-05	0.000256	CcSEcCtD
Levomilnacipran—Palpitations—Topiramate—epilepsy syndrome	4e-05	0.000253	CcSEcCtD
Levomilnacipran—Loss of consciousness—Topiramate—epilepsy syndrome	3.98e-05	0.000251	CcSEcCtD
Levomilnacipran—Insomnia—Gabapentin—epilepsy syndrome	3.97e-05	0.000251	CcSEcCtD
Levomilnacipran—Nausea—Lamotrigine—epilepsy syndrome	3.96e-05	0.00025	CcSEcCtD
Levomilnacipran—Paraesthesia—Gabapentin—epilepsy syndrome	3.95e-05	0.000249	CcSEcCtD
Levomilnacipran—Convulsion—Topiramate—epilepsy syndrome	3.92e-05	0.000248	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.92e-05	0.000247	CcSEcCtD
Levomilnacipran—Dyspnoea—Gabapentin—epilepsy syndrome	3.92e-05	0.000247	CcSEcCtD
Levomilnacipran—Hypertension—Topiramate—epilepsy syndrome	3.91e-05	0.000247	CcSEcCtD
Levomilnacipran—Somnolence—Gabapentin—epilepsy syndrome	3.91e-05	0.000247	CcSEcCtD
Levomilnacipran—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.9e-05	0.000247	CcSEcCtD
Levomilnacipran—Dyspepsia—Gabapentin—epilepsy syndrome	3.87e-05	0.000244	CcSEcCtD
Levomilnacipran—Chest pain—Topiramate—epilepsy syndrome	3.86e-05	0.000243	CcSEcCtD
Levomilnacipran—Anxiety—Topiramate—epilepsy syndrome	3.84e-05	0.000243	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.83e-05	0.000242	CcSEcCtD
Levomilnacipran—Decreased appetite—Gabapentin—epilepsy syndrome	3.82e-05	0.000241	CcSEcCtD
Levomilnacipran—Urticaria—Pregabalin—epilepsy syndrome	3.81e-05	0.00024	CcSEcCtD
Levomilnacipran—Asthenia—Valproic Acid—epilepsy syndrome	3.8e-05	0.00024	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.79e-05	0.000239	CcSEcCtD
Levomilnacipran—Fatigue—Gabapentin—epilepsy syndrome	3.79e-05	0.000239	CcSEcCtD
Levomilnacipran—Abdominal pain—Pregabalin—epilepsy syndrome	3.79e-05	0.000239	CcSEcCtD
Levomilnacipran—Body temperature increased—Pregabalin—epilepsy syndrome	3.79e-05	0.000239	CcSEcCtD
Levomilnacipran—Dry mouth—Topiramate—epilepsy syndrome	3.77e-05	0.000238	CcSEcCtD
Levomilnacipran—Constipation—Gabapentin—epilepsy syndrome	3.76e-05	0.000237	CcSEcCtD
Levomilnacipran—Pruritus—Valproic Acid—epilepsy syndrome	3.75e-05	0.000237	CcSEcCtD
Levomilnacipran—Infection—Topiramate—epilepsy syndrome	3.67e-05	0.000232	CcSEcCtD
Levomilnacipran—Shock—Topiramate—epilepsy syndrome	3.64e-05	0.00023	CcSEcCtD
Levomilnacipran—Diarrhoea—Valproic Acid—epilepsy syndrome	3.63e-05	0.000229	CcSEcCtD
Levomilnacipran—Nervous system disorder—Topiramate—epilepsy syndrome	3.62e-05	0.000229	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Topiramate—epilepsy syndrome	3.62e-05	0.000228	CcSEcCtD
Levomilnacipran—Tachycardia—Topiramate—epilepsy syndrome	3.61e-05	0.000228	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.59e-05	0.000227	CcSEcCtD
Levomilnacipran—Skin disorder—Topiramate—epilepsy syndrome	3.59e-05	0.000227	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Topiramate—epilepsy syndrome	3.57e-05	0.000226	CcSEcCtD
Levomilnacipran—Hypersensitivity—Pregabalin—epilepsy syndrome	3.53e-05	0.000223	CcSEcCtD
Levomilnacipran—Anorexia—Topiramate—epilepsy syndrome	3.52e-05	0.000222	CcSEcCtD
Levomilnacipran—Dizziness—Valproic Acid—epilepsy syndrome	3.5e-05	0.000221	CcSEcCtD
Levomilnacipran—Urticaria—Gabapentin—epilepsy syndrome	3.49e-05	0.00022	CcSEcCtD
Levomilnacipran—Abdominal pain—Gabapentin—epilepsy syndrome	3.47e-05	0.000219	CcSEcCtD
Levomilnacipran—Body temperature increased—Gabapentin—epilepsy syndrome	3.47e-05	0.000219	CcSEcCtD
Levomilnacipran—Hypotension—Topiramate—epilepsy syndrome	3.45e-05	0.000218	CcSEcCtD
Levomilnacipran—Asthenia—Pregabalin—epilepsy syndrome	3.44e-05	0.000217	CcSEcCtD
Levomilnacipran—Pruritus—Pregabalin—epilepsy syndrome	3.39e-05	0.000214	CcSEcCtD
Levomilnacipran—Vomiting—Valproic Acid—epilepsy syndrome	3.37e-05	0.000213	CcSEcCtD
Levomilnacipran—Insomnia—Topiramate—epilepsy syndrome	3.34e-05	0.000211	CcSEcCtD
Levomilnacipran—Rash—Valproic Acid—epilepsy syndrome	3.34e-05	0.000211	CcSEcCtD
Levomilnacipran—Dermatitis—Valproic Acid—epilepsy syndrome	3.34e-05	0.000211	CcSEcCtD
Levomilnacipran—Headache—Valproic Acid—epilepsy syndrome	3.32e-05	0.00021	CcSEcCtD
Levomilnacipran—Paraesthesia—Topiramate—epilepsy syndrome	3.32e-05	0.00021	CcSEcCtD
Levomilnacipran—Dyspnoea—Topiramate—epilepsy syndrome	3.3e-05	0.000208	CcSEcCtD
Levomilnacipran—Somnolence—Topiramate—epilepsy syndrome	3.29e-05	0.000207	CcSEcCtD
Levomilnacipran—Diarrhoea—Pregabalin—epilepsy syndrome	3.28e-05	0.000207	CcSEcCtD
Levomilnacipran—Dyspepsia—Topiramate—epilepsy syndrome	3.25e-05	0.000205	CcSEcCtD
Levomilnacipran—Hypersensitivity—Gabapentin—epilepsy syndrome	3.24e-05	0.000204	CcSEcCtD
Levomilnacipran—Decreased appetite—Topiramate—epilepsy syndrome	3.21e-05	0.000203	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.19e-05	0.000201	CcSEcCtD
Levomilnacipran—Fatigue—Topiramate—epilepsy syndrome	3.19e-05	0.000201	CcSEcCtD
Levomilnacipran—Dizziness—Pregabalin—epilepsy syndrome	3.17e-05	0.0002	CcSEcCtD
Levomilnacipran—Constipation—Topiramate—epilepsy syndrome	3.16e-05	0.0002	CcSEcCtD
Levomilnacipran—Asthenia—Gabapentin—epilepsy syndrome	3.15e-05	0.000199	CcSEcCtD
Levomilnacipran—Nausea—Valproic Acid—epilepsy syndrome	3.15e-05	0.000199	CcSEcCtD
Levomilnacipran—Pruritus—Gabapentin—epilepsy syndrome	3.11e-05	0.000196	CcSEcCtD
Levomilnacipran—Vomiting—Pregabalin—epilepsy syndrome	3.05e-05	0.000192	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.02e-05	0.000191	CcSEcCtD
Levomilnacipran—Rash—Pregabalin—epilepsy syndrome	3.02e-05	0.000191	CcSEcCtD
Levomilnacipran—Dermatitis—Pregabalin—epilepsy syndrome	3.02e-05	0.000191	CcSEcCtD
Levomilnacipran—Diarrhoea—Gabapentin—epilepsy syndrome	3.01e-05	0.00019	CcSEcCtD
Levomilnacipran—Headache—Pregabalin—epilepsy syndrome	3e-05	0.00019	CcSEcCtD
Levomilnacipran—Urticaria—Topiramate—epilepsy syndrome	2.94e-05	0.000185	CcSEcCtD
Levomilnacipran—Abdominal pain—Topiramate—epilepsy syndrome	2.92e-05	0.000184	CcSEcCtD
Levomilnacipran—Body temperature increased—Topiramate—epilepsy syndrome	2.92e-05	0.000184	CcSEcCtD
Levomilnacipran—Dizziness—Gabapentin—epilepsy syndrome	2.91e-05	0.000183	CcSEcCtD
Levomilnacipran—Nausea—Pregabalin—epilepsy syndrome	2.85e-05	0.00018	CcSEcCtD
Levomilnacipran—Vomiting—Gabapentin—epilepsy syndrome	2.79e-05	0.000176	CcSEcCtD
Levomilnacipran—Rash—Gabapentin—epilepsy syndrome	2.77e-05	0.000175	CcSEcCtD
Levomilnacipran—Dermatitis—Gabapentin—epilepsy syndrome	2.77e-05	0.000175	CcSEcCtD
Levomilnacipran—Headache—Gabapentin—epilepsy syndrome	2.75e-05	0.000174	CcSEcCtD
Levomilnacipran—Hypersensitivity—Topiramate—epilepsy syndrome	2.72e-05	0.000172	CcSEcCtD
Levomilnacipran—Asthenia—Topiramate—epilepsy syndrome	2.65e-05	0.000167	CcSEcCtD
Levomilnacipran—Pruritus—Topiramate—epilepsy syndrome	2.62e-05	0.000165	CcSEcCtD
Levomilnacipran—Nausea—Gabapentin—epilepsy syndrome	2.61e-05	0.000165	CcSEcCtD
Levomilnacipran—Diarrhoea—Topiramate—epilepsy syndrome	2.53e-05	0.00016	CcSEcCtD
Levomilnacipran—Dizziness—Topiramate—epilepsy syndrome	2.44e-05	0.000154	CcSEcCtD
Levomilnacipran—Vomiting—Topiramate—epilepsy syndrome	2.35e-05	0.000148	CcSEcCtD
Levomilnacipran—Rash—Topiramate—epilepsy syndrome	2.33e-05	0.000147	CcSEcCtD
Levomilnacipran—Dermatitis—Topiramate—epilepsy syndrome	2.33e-05	0.000147	CcSEcCtD
Levomilnacipran—Headache—Topiramate—epilepsy syndrome	2.32e-05	0.000146	CcSEcCtD
Levomilnacipran—Nausea—Topiramate—epilepsy syndrome	2.2e-05	0.000139	CcSEcCtD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.07e-05	0.000225	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—COX3—epilepsy syndrome	1.07e-05	0.000225	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	1.05e-05	0.000221	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GBE1—epilepsy syndrome	1.05e-05	0.000221	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.04e-05	0.000218	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.03e-05	0.000216	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.03e-05	0.000216	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	1.01e-05	0.000213	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PFKL—epilepsy syndrome	1.01e-05	0.000213	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	1.01e-05	0.000213	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	1.01e-05	0.000213	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	1.01e-05	0.000213	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ATIC—epilepsy syndrome	1.01e-05	0.000212	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NEU1—epilepsy syndrome	1.01e-05	0.000212	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—UPB1—epilepsy syndrome	1.01e-05	0.000212	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	9.99e-06	0.00021	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	9.87e-06	0.000208	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ATIC—epilepsy syndrome	9.84e-06	0.000207	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NEU1—epilepsy syndrome	9.84e-06	0.000207	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—UPB1—epilepsy syndrome	9.84e-06	0.000207	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	9.78e-06	0.000206	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	9.7e-06	0.000204	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	9.6e-06	0.000202	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	9.47e-06	0.000199	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—POMC—epilepsy syndrome	9.46e-06	0.000199	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GBE1—epilepsy syndrome	9.37e-06	0.000197	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	9.37e-06	0.000197	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NT5E—epilepsy syndrome	9.35e-06	0.000197	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALAD—epilepsy syndrome	9.35e-06	0.000197	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	9.29e-06	0.000195	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NEU1—epilepsy syndrome	9.27e-06	0.000195	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ATIC—epilepsy syndrome	9.27e-06	0.000195	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—UPB1—epilepsy syndrome	9.27e-06	0.000195	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	9.16e-06	0.000193	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GBE1—epilepsy syndrome	9.14e-06	0.000192	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	9.14e-06	0.000192	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.09e-06	0.000191	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	8.92e-06	0.000188	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	8.92e-06	0.000188	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	8.92e-06	0.000188	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	8.82e-06	0.000186	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	8.81e-06	0.000185	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	8.74e-06	0.000184	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	8.74e-06	0.000184	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PDXK—epilepsy syndrome	8.74e-06	0.000184	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CERS1—epilepsy syndrome	8.74e-06	0.000184	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADK—epilepsy syndrome	8.74e-06	0.000184	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—FAR1—epilepsy syndrome	8.74e-06	0.000184	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	8.73e-06	0.000184	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ALB—epilepsy syndrome	8.62e-06	0.000181	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GBE1—epilepsy syndrome	8.62e-06	0.000181	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	8.62e-06	0.000181	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ASAH1—epilepsy syndrome	8.6e-06	0.000181	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	8.57e-06	0.00018	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADSL—epilepsy syndrome	8.56e-06	0.00018	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.5e-06	0.000179	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GLUL—epilepsy syndrome	8.39e-06	0.000177	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—STXBP1—epilepsy syndrome	8.36e-06	0.000176	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NT5E—epilepsy syndrome	8.35e-06	0.000176	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALAD—epilepsy syndrome	8.35e-06	0.000176	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	8.24e-06	0.000173	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	8.19e-06	0.000172	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NT5E—epilepsy syndrome	8.15e-06	0.000171	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALAD—epilepsy syndrome	8.15e-06	0.000171	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	8.11e-06	0.000171	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	8.1e-06	0.00017	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	8e-06	0.000168	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PNPO—epilepsy syndrome	8e-06	0.000168	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GAMT—epilepsy syndrome	8e-06	0.000168	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	8e-06	0.000168	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	7.97e-06	0.000168	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	7.97e-06	0.000168	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	7.95e-06	0.000167	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	7.88e-06	0.000166	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	7.8e-06	0.000164	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	7.78e-06	0.000164	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	7.78e-06	0.000164	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	7.7e-06	0.000162	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NT5E—epilepsy syndrome	7.68e-06	0.000162	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALAD—epilepsy syndrome	7.68e-06	0.000162	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADSL—epilepsy syndrome	7.64e-06	0.000161	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	7.61e-06	0.00016	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS2—epilepsy syndrome	7.54e-06	0.000159	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GLUL—epilepsy syndrome	7.49e-06	0.000158	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AQP1—epilepsy syndrome	7.48e-06	0.000157	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADSL—epilepsy syndrome	7.45e-06	0.000157	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CA4—epilepsy syndrome	7.43e-06	0.000156	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—QDPR—epilepsy syndrome	7.43e-06	0.000156	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	7.41e-06	0.000156	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	7.35e-06	0.000155	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	7.33e-06	0.000154	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	7.33e-06	0.000154	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GLUL—epilepsy syndrome	7.31e-06	0.000154	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.18e-06	0.000151	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	7.18e-06	0.000151	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	7.17e-06	0.000151	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	7.14e-06	0.00015	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADSL—epilepsy syndrome	7.02e-06	0.000148	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—COX3—epilepsy syndrome	6.99e-06	0.000147	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.95e-06	0.000146	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GLUL—epilepsy syndrome	6.89e-06	0.000145	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	6.88e-06	0.000145	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	6.76e-06	0.000142	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	6.76e-06	0.000142	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	6.76e-06	0.000142	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	6.71e-06	0.000141	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AQP1—epilepsy syndrome	6.68e-06	0.00014	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.67e-06	0.00014	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	6.63e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	6.63e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	6.63e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PFKL—epilepsy syndrome	6.63e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	6.63e-06	0.000139	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.61e-06	0.000139	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AQP1—epilepsy syndrome	6.52e-06	0.000137	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.41e-06	0.000135	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	6.32e-06	0.000133	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.3e-06	0.000133	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.17e-06	0.00013	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AQP1—epilepsy syndrome	6.14e-06	0.000129	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NEU1—epilepsy syndrome	6.06e-06	0.000127	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ATIC—epilepsy syndrome	6.06e-06	0.000127	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—UPB1—epilepsy syndrome	6.06e-06	0.000127	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	6.04e-06	0.000127	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	6.04e-06	0.000127	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.96e-06	0.000125	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	5.89e-06	0.000124	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CHRM3—epilepsy syndrome	5.89e-06	0.000124	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.83e-06	0.000123	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.63e-06	0.000119	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.63e-06	0.000119	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.62e-06	0.000118	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	5.55e-06	0.000117	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	5.55e-06	0.000117	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	5.51e-06	0.000116	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.51e-06	0.000116	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	5.37e-06	0.000113	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	5.34e-06	0.000112	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.3e-06	0.000112	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	5.3e-06	0.000111	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	5.15e-06	0.000108	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.02e-06	0.000106	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.02e-06	0.000106	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.92e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.83e-06	0.000102	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	4.82e-06	0.000101	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.8e-06	0.000101	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.79e-06	0.000101	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.79e-06	0.000101	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.77e-06	0.0001	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.73e-06	9.95e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.69e-06	9.86e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.68e-06	9.85e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.65e-06	9.79e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.59e-06	9.66e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	4.59e-06	9.65e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—BCHE—epilepsy syndrome	4.57e-06	9.61e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	4.53e-06	9.52e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.5e-06	9.47e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.43e-06	9.33e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	4.42e-06	9.3e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	4.41e-06	9.28e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	4.38e-06	9.22e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	4.36e-06	9.17e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.31e-06	9.08e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	4.31e-06	9.07e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	4.3e-06	9.05e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TH—epilepsy syndrome	4.3e-06	9.04e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.23e-06	8.9e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	4.2e-06	8.83e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.13e-06	8.7e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	4.09e-06	8.61e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—BCHE—epilepsy syndrome	4.08e-06	8.58e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.01e-06	8.44e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4e-06	8.42e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	4e-06	8.41e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.98e-06	8.37e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.89e-06	8.18e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.85e-06	8.09e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TH—epilepsy syndrome	3.83e-06	8.07e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.8e-06	7.99e-05	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKT1—epilepsy syndrome	3.79e-06	7.98e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.77e-06	7.94e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.77e-06	7.92e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.76e-06	7.9e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.75e-06	7.89e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TH—epilepsy syndrome	3.74e-06	7.87e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.63e-06	7.64e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.63e-06	7.64e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	3.58e-06	7.54e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	3.58e-06	7.53e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	3.54e-06	7.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CAT—epilepsy syndrome	3.54e-06	7.44e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TH—epilepsy syndrome	3.53e-06	7.42e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	3.44e-06	7.24e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	3.2e-06	6.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GPX1—epilepsy syndrome	3.2e-06	6.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CAT—epilepsy syndrome	3.16e-06	6.64e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMOX1—epilepsy syndrome	3.12e-06	6.57e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CAT—epilepsy syndrome	3.08e-06	6.48e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	3.07e-06	6.46e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.96e-06	6.23e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.94e-06	6.19e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.9e-06	6.11e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.88e-06	6.07e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.87e-06	6.03e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.86e-06	6.01e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.82e-06	5.94e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AGT—epilepsy syndrome	2.81e-06	5.9e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.79e-06	5.86e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOE—epilepsy syndrome	2.75e-06	5.78e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.63e-06	5.52e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.59e-06	5.44e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.5e-06	5.27e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.46e-06	5.18e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.45e-06	5.16e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.45e-06	5.16e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AGT—epilepsy syndrome	2.44e-06	5.14e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOE—epilepsy syndrome	2.39e-06	5.04e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—POMC—epilepsy syndrome	2.36e-06	4.97e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.34e-06	4.92e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.31e-06	4.87e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TH—epilepsy syndrome	2.31e-06	4.85e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.3e-06	4.84e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.26e-06	4.75e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—epilepsy syndrome	2.15e-06	4.53e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.11e-06	4.43e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—POMC—epilepsy syndrome	2.06e-06	4.33e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.94e-06	4.08e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.92e-06	4.05e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.92e-06	4.04e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.9e-06	3.99e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	1.88e-06	3.96e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—epilepsy syndrome	1.88e-06	3.95e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.85e-06	3.89e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.77e-06	3.72e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.72e-06	3.61e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.68e-06	3.54e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.64e-06	3.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.55e-06	3.25e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.51e-06	3.17e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.48e-06	3.1e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.27e-06	2.67e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.16e-06	2.43e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.01e-06	2.13e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKT1—epilepsy syndrome	9.46e-07	1.99e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKT1—epilepsy syndrome	8.45e-07	1.78e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKT1—epilepsy syndrome	8.25e-07	1.73e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKT1—epilepsy syndrome	7.77e-07	1.63e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKT1—epilepsy syndrome	5.08e-07	1.07e-05	CbGpPWpGaD
